Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL12(p40) | 253.0 | 56 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL12(p40) | 258.0 | 59 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL12(p40) | 260.0 | 53 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL12(p40) | 218.0 | 57 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | IL12(p40) | 168.0 | 50 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL12(p40) | 225.0 | 42 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | IL12(p40) | 215.0 | 73 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | IL12(p40) | 240.0 | 52 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | IL12(p40) | 253.5 | 48 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 197.0 | 61 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 143.0 | 69 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 201.0 | 54 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 187.0 | 59 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 228.5 | 76 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 214.5 | 62 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 142.0 | 77 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 117.0 | 44 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 177.5 | 54 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 155.0 | 49 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 210.0 | 43 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | IL12(p40) | 189.0 | 45 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL12(p40) | 158.0 | 45 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | IL12(p40) | 205.0 | 67 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL12(p40) | 231.5 | 70 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | IL12(p40) | 253.0 | 60 |